3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
55
Recurrence
14
Neoplasms, Plasma Cell
9
Primary Myelofibrosis
3
Polycythemia Vera
3
Neoplasms
3
Waldenstrom Macroglobulinemia
2
Plasmacytoma
2
Myeloproliferative Disorders
2
Hematologic Diseases
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sarcoma, Kaposi
1
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Hodgkin Disease
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
venetoclax
4
fludarabine phosphate
3
ibrutinib
2
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
pembrolizumab
1
obinutuzumab
1
ixazomib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
auricularum
1
acalabrutinib
1
Tacrolimus
1
RG7388
1
Nivolumab
1
Melphalan
1
Etoposide
1
Dexamethasone
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chromosome 17 deletion
×
pomalidomide
×
Clear all
No trials found.